MDA

OTHER4 trials

Sponsors

Laboratory of Endocrine and Metabolism of West China Hospital, Sichuan University, California Pacific Medical Center Research Institute, University Hospital, Brest, London School of Hygiene and Tropical Medicine

Conditions

DepressionHealthyMalariaType 2 diabetes

Phase 1

Serum gamma-glutamyltransferase, Ferritin, uric acid and their interaction on the risk of type 2 diabetes

Active, not recruitingChiCTR-OCS-09000361

Laboratory of Endocrine and Metabolism of West China Hospital, Sichuan UniversityType 2 diabetes

Start: 2007-06-01Updated: 2017-04-18

Unknown Phase

Clinical Pharmacology of MDA [3,4-methylenedioxyamphetamine]

CompletedNCT00823407

California Pacific Medical Center Research InstituteHealthy

Start: 2009-01-31End: 2009-07-31Updated: 2013-05-31

Adolescent Depression Associated With Parental Depression

TerminatedNCT03811041

University Hospital, BrestDepression

Start: 2019-03-28End: 2021-03-11Updated: 2022-04-11

P. Falciparum Infection Dynamics and Transmission to Inform Elimination

London School of Hygiene and Tropical MedicineMalaria

Start: 2019-08-15End: 2022-05-31Target: 4000Updated: 2022-03-31

Related Papers

Vitamin D and Incidence of Prediabetes or Type 2 Diabetes: A Four-Year Follow-Up Community-Based Study

Disease Markers2018-01-0155 citations

Investigating the mechanisms of hallucinogen-induced visions using 3,4-methylenedioxyamphetamine (MDA): a randomized controlled trial in humans.

2010-12-0213 citations